Nós utilizamos cookies para otimizar o website. Se você continuar navegando no site ou se fechar esta janela, você aceita nossa política de cookies

Esse conteúdo do nosso site está disponível apenas em inglês
Imprimir Compartilhe

​Cees de Jong will step down as CEO of Chr. Hansen Holding A/S

​Cees de Jong will step down as CEO of Chr. Hansen Holding A/S
Press ReleaseNov 28. 2017 07:03 GMT

Chr. Hansen’s Chief Executive Officer Cees de Jong has informed the Company that after having led Chr. Hansen as CEO for almost 5 years, he intends to pursue a career as a non-executive director outside Chr. Hansen in due course.

The Company has initiated a process to find his replacement, and until then Cees de Jong will continue as CEO of Chr. Hansen.

Ole Andersen, Chairman of the Company’s Board of Directors, says: “Cees has done a tremendous job for Chr. Hansen and its shareholders, employees and other stakeholders. Together with the Corporate Leadership Team, Cees has steered the Company while delivering in accordance with our financial goals, helped develop an ambitious strategy and been a driving force behind our initiatives to pursue new growth opportunities. Chr. Hansen will be in a much stronger shape when Cees leaves, than when he arrived. We have several new and exciting prospects. I therefore look forward to identifying and appointing a new CEO for Chr. Hansen among the very strong candidates there will naturally be for this attractive position.”

Cees de Jong says: “Chr. Hansen has a unique competence base and strong growth prospects, and it is, and has been, a privilege to be the CEO since 2013. The Company and its employees have been creating excellent results and are continuing to deliver on the “Nature’s No. 1” strategy, turning Chr. Hansen into a true global microbial solutions company. While I am choosing now to pursue a different career, I will continue fully dedicated in my role as CEO for Chr. Hansen until my replacement has been found”.


A Chr. Hansen é uma empresa global de biociência, que desenvolve soluções com ingredientes naturais para as indústrias alimentícia, nutricional, farmacêutica e agrícola. Os produtos incluem culturas, enzimas, probióticos e corantes naturais, e todas as soluções baseiam-se em sólidas competências em pesquisa e desenvolvimento, além de significativos investimentos em tecnologia. A receita para o ano fiscal 2015/16 foi de 949 milhões de euros. A empresa tem mais de 2.800 funcionários em 30 países, e centros principais de produção na Dinamarca, França, EUA e Alemanha. A Chr. Hansen foi fundada em 1874 e está listada na Nasdaq Copenhague.

O que você procura?

Compartilhe esta página

Selecione o seu idioma de preferência